Catalyst Wire Dossier Catalyst Wire Dossier

Premarin 0.625 mg/MPA 2.5 mg

conjugated estrogens/medroxyprogesterone acetate · Wyeth
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Premarin 0.625 mg/MPA 2.5 mg, covering 2009-02-04 to 2009-02-04. Get the full timeline:

Most recent: Clinical Trial Update: Study Comparing 3 New Formulations of Premarin® 0.625 mg/MPA 2.5 mg With a Reference Formulation [Phase 1]

See pricing